Article Details
Retrieved on: 2018-02-01 03:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Pardoll receives research support from Bristol-Myers Squibb, Compugen, Ervaxx and Potenza, and is a scientific advisory board member for <b>Immunomic</b> <b>Therapeutics</b>. He shares intellectual property with Aduro Biotech, Bristol-Myers Squibb, Compugen, and <b>Immunomic Therapeutics</b>. All other authors ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here